Details for New Drug Application (NDA): 202138
✉ Email this page to a colleague
The generic ingredient in KEMEYA is drospirenone; ethinyl estradiol. There are eleven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the drospirenone; ethinyl estradiol profile page.
Summary for 202138
Tradename: | KEMEYA |
Applicant: | Sun Pharm |
Ingredient: | drospirenone; ethinyl estradiol |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL-28 | Strength | 3MG;0.03MG | ||||
Approval Date: | Mar 13, 2019 | TE: | RLD: | No |
Complete Access Available with Subscription